triumph 1 trial retatrutide TRIUMPH-1 results: Retatrutide, the triple agonist. Significant weight loss ( 28.3% average loss at 80 weeks). It has potential to transform obesity treatment with results comparable to… A Study of Retatrutide (LY3437943)

Glucuronidation may speed clearance of paracetamol, diazepam and morphine

Arumugam R, Subramanyam V, Chinnadurai RK et al (2019) Development of novel mechanically stable porous nanocomposite (PVDF-PMMA/HAp/TiO2) film scaffold with nanowhiskers surface morphology for bone repair applications

Taking a GLP-1 medication can change how you think about food

A pragmatic perioperative counseling and risk-minimization framework is proposed for orthopaedic surgical patients reporting peptide exposure ( Figure 1 )

Raschi et al utilized the US Food and Drug Administration Adverse Event Reporting System in an early study

The combination of monounsaturated fats and fiber slows digestion, stabilizes blood sugar levels, and prevents rapid spikes and crashes in energy